You are here

Cardiovascular Disease Management

Managing patients with cardiovascular disease (CVD) goes beyond treating their symptoms; it involves the ongoing management of their condition in order to help reduce the risk of potentially fatal events.

Consider that atrial fibrillation (AF) is associated with 5-fold increase in the risk of strokes.1 Similarly, within 3 months of hospitalization for deep vein thrombosis (DVT) or pulmonary embolism (PE), two-thirds of recurrent events occurred in the first month postdischarge.2 Among study patients who stopped taking prescribed anticoagulants, 29.1% experienced a recurrent VTE at 5 years, while 12% of all recurrent VTEs resulted in a fatal event.3

The tools and resources available through the Janssen CarePath Healthy Engagements program can help inform your patients about cardiovascular conditions. Effective management can help reduce the risk of cardiovascular events such as DVT and PE. You will also find additional resources designed to support improved care coordination among healthcare professionals to engage and align efforts around improving quality of care, transitions of care, and ultimately, patient outcomes. 

Explore tools supporting patient medication adherence and promoting maintenance of a healthcare routine.

View resources designed to activate patients to be engaged in the care management of CVD.

Explore resources designed to support improved care coordination efforts among providers and enhance communication between providers and patients.

Janssen tools and resources have not been proven to improve outcomes and may not completely address the specific intervention activities listed on each page. Janssen tools or resources discussed should be evaluated against other available sources of information before decisions are made about how to approach patient care within your organization. Full descriptions of appropriate use and associated limitations are set forth in the respective tools and resources.

This information has been developed by Janssen Pharmaceuticals, Inc., and made widely available to support patient and provider education.

Reference:

  1. January CT, Wann LS, Alpert JS, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1-e76.
  2. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996;61(2):755-759.
  3. Spencer FA, Lessard D, Emery C, Reed G, Goldberg RJ. Venous thromboembolism in the outpatient setting. Arch Intern Med. 2007;167(14):1471-1475.
  4. Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007;92(2):199-205.

Click here to browse the full library of available resources.